Please provide your email address to receive an email when new articles are posted on . Among patients with low baseline HBsAg, 39% achieved HBsAg loss with tobevibart/elebsiran, which rose to 46% ...

Please provide your email address to receive an email when new articles are posted on . In this video, Mark Sulkowski, MD, discusses the AASLD updated practice guidelines on the treatment of patients ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). Acute HPV comes on quickly and resolves promptly. Chronic HBV is a long-term infection, lasting for at least 6 months. The ...

Douglas T. Dieterich, MD, Director, Institute for Liver Medicine and Professor of Medicine at Icahn School of Medicine in New York City, focuses on the emerging use of hepatitis B surface antigen, ...

Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of ...

Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...

Hepatitis B (HBV) is a viral infection that affects the liver by causing inflammation. This can lead to permanent scarring, what medical professionals call liver fibrosis or cirrhosis. Most hepatitis ...